The National Institute for Health and Care Excellence (NICE) have published new or updated guidance for the month of May 2025. This month there is one guideline and one technology appraisal that impact upon primary care.
The Suspected cancer: recognition and referral guideline has been updated. It covers identifying children, young people and adults with symptoms that could be caused by cancer. The update amended referral criteria for suspected upper gastrointestinal tract cancers.
The Cenobamate for treating focal onset seizures in epilepsy technology appraisal has been updated. Recommendation 1.1 has been updated to allow healthcare professionals with expertise in epilepsy to commence treatment to reduce inequity of access to the treatment. After commencement, treatment can be continued in primary care.
Action: Clinicians should be aware of this month's new guidance and implement any necessary changes to practice.